Picture of Torrent Pharmaceuticals logo

TORNTPHARM — Torrent Pharmaceuticals News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Indian drugmaker Torrent Pharma's quarterly profit jumps on strong demand

July 28 (Reuters) - India's Torrent Pharma TORP.NS reported a 20% jump in its first-quarter profit on Monday, driven by demand for drugs used to treat long-term conditions.

The firm's consolidated net profit rose to 5.48 billion rupees ($63.2 million) for the quarter ended June 30, from 4.57 billion rupees year ago.

Its total revenue grew 11% to 31.78 billion rupees, surpassing analysts' estimates of 31.57 billion rupees, as per data compiled by LSEG.

For further earnings highlights, click nFWN3TP1EH.

KEY CONTEXT

Torrent Pharma, which makes drugs for treating conditions such as diabetes, infections, and cancer, continued to benefit from strong domestic demand for these medicines.

Revenue from India, which contributed around 56% to the total, jumped 11% from a year earlier. This was led by strong demand for Torrent's therapies such as cardiovascular, gastro-intestinal and anti-infectives.

Diabetes, which is one of Torrent's key therapy areas, led demand in the Indian pharmaceutical market, which grew 8% in June, according to data from India Ratings and Research.

PEER COMPARISON

Estimates (next 12 months)Analysts' sentiment
RICPEEV/EBITDARevenue growth (%)Profit growth (%)Mean rating*# of analystsStock to price target**
Torrent Pharmaceuticals LtdTORP.NS45.2727.1212.5625.29Buy280.98
Mankind Pharma LtdMNKI.NS46.4127.7218.0513.86Buy150.96
J B Chemicals and Pharmaceuticals LtdJBCH.NS31.7620.8412.4218.96Buy120.86
Glenmark Pharmaceuticals LtdGLEN.NS32.2819.6612.3525.06Buy91.02
* Mean of analysts' ratings standardised to a scale of Strong Buy, Buy, Hold, Sell, and Strong Sell ** Ratio of the stock's last close to analysts' mean price target; a ratio above 1 means the stock is trading above the PT APRIL TO JUNE STOCK PERFORMANCE -- $1 = 86.6530 Indian rupees TORRENT PHARMA'S STOCK PERFORMANCE IN Q1 COMPARED TO PEERS https://reut.rs/4o7400W (Reporting by Kashish Tandon in Bengaluru; Editing by Mrigank Dhaniwala) ((Kashish.Tandon@thomsonreuters.com; 8800437922;))

Recent news on Torrent Pharmaceuticals

See all news